Xylem (XYL)
(Delayed Data from NYSE)
$119.46 USD
-2.32 (-1.91%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $119.45 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$119.46 USD
-2.32 (-1.91%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $119.45 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Zacks News
Best Income Stocks to Buy for August 7th
by Zacks Equity Research
ETD, OSK and XYL made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 7, 2023.
Xylem (XYL) Q2 Earnings & Revenues Top Estimates, '23 View Up
by Zacks Equity Research
Xylem's (XYL) Q2 results benefit from strong commercial and operational execution and contribution from the Evoqua acquisition. Following strong performance, the company raises its 2023 guidance.
Xylem (XYL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Xylem (XYL) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Xylem (XYL) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 15.29% and 2.98%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Barnes Group (B) Q2 Earnings Beat Estimates
by Zacks Equity Research
Barnes Group (B) delivered earnings and revenue surprises of 7.41% and 0.34%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Xylem (XYL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3M's (MMM) Q2 Earnings & Revenues Beat Estimates, '23 EPS View Up
by Zacks Equity Research
3M (MMM) reports better-than-expected Q2 results despite pre-tax charges of $10.3 billion related to PFAS settlement. The company raises its 2023 earnings guidance owing to cost-control measures.
Xylem (XYL) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Increasing costs and expenses, as well as forex woes, are likely to have hurt Xylem's (XYL) Q2 performance.
Honeywell (HON) Up 21% in a Year: Will the Momentum Continue?
by Zacks Equity Research
Strength in the Aerospace segment, pricing actions and cost-control measures augur well for Honeywell's (HON) growth. The company's shareholder-friendly policies are encouraging.
Cintas (CTAS) Q4 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Cintas' (CTAS) Q4 results benefit from higher organic sales. Earnings increased 18.5% year over year despite higher costs.
Here's Why A. O. Smith (AOS) Should Grace Your Portfolio Now
by Zacks Equity Research
Improving supply chains and robust demand for boilers and water treatment products bode well for A. O. Smith (AOS).
Honeywell (HON) to Acquire Cybersecurity Business, SCADAfence
by Zacks Equity Research
Honeywell's (HON) acquisition of SCADAfence expands its OT cybersecurity portfolio, offering customers enhanced asset discovery, threat detection and compliance management capabilities.
Should You Invest in the Invesco Water Resources ETF (PHO)?
by Zacks Equity Research
Sector ETF report for PHO
Should You Invest in the Invesco S&P Global Water Index ETF (CGW)?
by Zacks Equity Research
Sector ETF report for CGW
Best Momentum Stocks to Buy for June 26th
by Zacks Equity Research
XYL, JHX and TGS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 26, 2023.
Is Invesco Water Resources ETF (PHO) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PHO
Xylem (XYL) Surges 52% in a Year: Will the Momentum Continue?
by Zacks Equity Research
Xylem (XYL) gains from strong demand across its end markets and improving supply chains. The Evoqua acquisition is expected to bolster its growth.
Best Income Stocks to Buy for June 16th
by Zacks Equity Research
INGR, BTVCY and XYL made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 16, 2023.
Xylem (XYL) Upgraded to Buy: Here's Why
by Zacks Equity Research
Xylem (XYL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Xylem (XYL) Closes Evoqua Deal, Boosts Water Service Portfolio
by Zacks Equity Research
Xylem's (XYL) acquisition of Evoqua bolsters its position in water technologies, solutions and services, and strengthens its foothold in lucrative end markets.
Xylem (XYL) Exhibits Strong Prospects Despite Headwinds
by Zacks Equity Research
While strong segmental performance and strong backlogs bode well for Xylem (XYL), rising operating costs are a major headwind.
Xylem (XYL) Q1 Earnings & Revenues Beat, 2023 View Raised
by Zacks Equity Research
Xylem's (XYL) Q1 results benefit from effective price realization and strong demand across end markets. Anticipating the demand strength to continue, the company improves its 2023 outlook.
Xylem (XYL) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 16.13% and 8%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Xylem (XYL) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Xylem (XYL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Xylem (XYL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Xylem (XYL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.